ASCIA (Australasian Society of Clinical Immunology and Allergy Limited) was established in 1990 as the peak professional body of clinical immunology and allergy in Australia and New Zealand. ASCIA is registered as a Company limited by guarantee (ACN 608 798 241; ABN 45 615 521 452).

In 2013 ASCIA established AIFA (Allergy and Immunology Foundation of Australasia) to fund research and raise awareness. ASCIA and AIFA are registered with the Australian Charities and Not-for-profits Commission (ACNC) 

In 2015 ASCIA and Allergy & Anaphylaxis Australia developed the first National Allergy Strategy for Australia, in conjunction with other key stakeholders.  Implementation of the National Allergy Strategy commenced in 2016-2017.  

This webpage includes the following information about ASCIA:

ASCIA Mission  

Advance the science and practice of allergy and clinical immunology, by promoting the highest standard of medical practice, training, education and research, to improve the health and quality of life of people with immune system disorders.  These include allergic diseases, immunodeficiencies and other immune diseases.

ASCIA Objectives

  1. Standards - Promote the highest standards of allergy and immunology medical training, practice and care.
  2. Education - Provide high quality allergy and immunology education for ASCIA members, other health professionals, patients, consumers and carers.
  3. Advice - Utilise ASCIA and stakeholder expertise to address allergy and immunology issues, provide advice and representation to government and other organisations.
  4. Advocacy - Increase the profile of allergy, immunology and immunopathology and advocate for patients.
  5. Research - Promote and fund research to improve health and quality of life of people with allergy and other immune diseases.
ASCIA Affiliations

ASCIA is a member society of the World Allergy Organisation (WAO) and the Asia Pacific Association of Allergy, Asthma and Clinical Immunology (APAAACI). ASCIA is also affiliated with the Royal Australasian College of Physicians (RACP) as a specialty society.  

As a specialty society affiliated with the RACP, ASCIA supports the RACP "Working Together" policy for staff, trainees, fellows and associates. This policy outlines the expected code of conduct to support fair treatment for all, without bullying, discrimination or harassment.  The policy is available on the RACP website: www.racp.edu.au/docs/default-source/default-document-library/working-together-policy.pdf?sfvrsn=2

ASCIA Membership

ASCIA members are health professionals who work in the areas of allergy, clinical immunology and immunopathology. Currently there is a total of 680 ASCIA members, comprising 263 Full ASCIA members and 417 ASCIA Associates. All members are listed on the members section of the ASCIA website website www.allergy.org.au/members/directory

Full ASCIA members are mainly clinical immunology/allergy specialists and they are listed on the ASCIA website How to loccate a specialist section www.allergy.org.au/patients/locate-a-specialist

ASCIA Associates include medical practitioners (e.g. GPs, paediatricians), other health professionals (e.g. nurses, dietitians, pharmacists), scientists/researchers, trainee clinical immunology/allergy specialists and retired ASCIA members.  There are currently: 

  • 131 Medical Associates who are medical practitioners with an interest in allergy, but are not clinical immunology/allergy specialists. 
  • 163 Other Health Professional Associates, which includes 115 nurses and 43 dietitians 
  • 38 Scientist/Researcher Associates 
  • 65 Trainee Associates who are undergoing advanced physician training to become clinical immunology/allergy specialists 

Membership applications are available from the ASCIA website www.allergy.org.au/members/apply

ASCIA members diagnose, treat and manage patients with allergies, immunodeficiencies and other immune diseases.

Allergic diseases are amongst the fastest growing chronic disease and public health issues in Australia and New Zealand, affecting around 20% of the population. They include food, insect and drug allergies, asthma, allergic rhinitis (hay fever) and eczema. Allergic diseases, particularly food allergy and drug allergy, are increasing in prevalence, complexity and severity.  The most severe type of allergic reaction is known as anaphylaxis, which is potentially life threatening. 

Immunodeficiency diseases are serious, potentially life threatening conditions that are increasing in number and complexity. Delay in diagnosis of immunodeficiency disease leads to poor health outcomes and premature death.

There are more than 100 different autoimmune diseases that affect around 5% of the population and if not appropriately managed, these can lead to significant disability. 

ASCIA Initiatives 

1: Standards

  • ASCIA Action Plans for Anaphylaxis and Guidelines were first developed in 2003 and are regularly reviewed and updated, including amendments as a result of coronial inquiry recommendations.
  • These standardised plans and guidelines, as well as ASCIA anaphylaxis e-training courses (first developed in 2010) are used throughout Australia and New Zealand, to provide a consistent approach to prevention, recognition and emergency treatment of anaphylaxis.
  • ASCIA action plans, guidelines and other resources that promote high standards are available open access from ASCIA website
  • ASCIA collaborates with other groups to improve patient care e.g. TAPID (transplantation and PID) project.

2: Education

3: Advice

  • 1st ASCIA Infant Feeding Advice and Allergy Prevention Guidelines were released in 2008.
  • 1st region worldwide to significantly update guidelines based on recently published studies and reviews in 2016.
  • ASCIA information for patients, consumers and carers is available open access from ASCIA website - first developed in 2000, this information is regularly reviewed, updated and augmented.

4: Advocacy

  • In 2013 ASCIA established the Allergy and Immunology Foundation of Australasia (AIFA) to fund research and increase awareness.
  • In 2015 the 1st National Allergy Strategy for Australia was developed by ASCIA in partnership with Allergy & Anaphylaxis Australia, in collaboration with other stakeholders.
  • Government funding for the National Allergy Strategy was secured for 1st and 2nd stages of implementation (2016-2019).

5: Research

  • From 2004 to 2008 ASCIA awarded $325,500 for allergy and immunology research projects.
  • In 2013 ASCIA established AIFA to fund research and raise awareness of allergy and other immune diseases.
  • Two projects that have received AIFA seed funding grants have subsequently  been awarded NHMRC funding.
  • To date $130,000 in AIFA grants have been awarded.

6: Sustainability

 It is important in the long term that ASCIA: 

  • Maintains existing funding and identifies new funding sources
  • Reinforces reputation and strengthens brands
  • Responds efficiently to supply and regulatory issues
  • Maintains staff and increases capacity
  • Retains and grows membership 

Further information 

ASCIA Committees and working parties

The following ASCIA committees are standing committees of the ASCIA Council, with representation on Council:

  • ASCIA Anaphylaxis committee
  • ASCIA Drug Allergy committee
  • ASCIA Education committee
  • ASCIA Immunodeficiency committee
  • ASCIA Laboratory Practice committee
  • ASCIA Paediatric committee
  • ASCIA Nurses committee
  • ASCIA Dietitians committee

In addition to the above mentioned committees there are ASCIA working parties and interest groups, which are not standing committees of the ASCIA Council.

Further information is available at www.allergy.org.au/members/committees 

For qualifications of members go to www.allergy.org.au/patients/locate-a-specialist 

ASCIA Sponsorship 

ASCIA educational activities include:

  • Health professional programs (e.g. ASCIA Annual Conferences, advanced training meetings, e-training courses, clinical updates, guidelines, position/consensus statements, action plans, treatment/management plans, checklists, anaphylaxis resources, registers).
  • Public education programs (e.g. ASCIA information for patients, consumers and carers, anaphylaxis resources, e-training courses for schools, childcare services and e-training courses for the community.

ASCIA educational activities are dependent on:

  • Funding derived from membership fees, educational grants from governments for specific projects and unrestricted educational grants from industry.
  • ASCIA members providing their expertise and time pro-bono.

For more details about sponsors and the ASCIA sponsorship policy go to www.allergy.org.au/about-ascia/sponsors 

ASCIA Conferences and meetings 

ASCIA Annual Conferences are usually held in September, with locations rotating between Australian states and New Zealand on approximately a six year cycle. Further information is available at www.allergy.org.au/conferences/ascia-annual-conference

In addition there are more regular educational meetings for ASCIA members which are organised by local ASCIA area representatives. Sponsorship of these meetings is not included in the ASCIA sponsorship categories listed above, as they are regional specific events.

ASCIA Update Newsletter

ASCIA Update is a free e-newsletter that provides current news to the community about new or updated resources and other relevant information about allergy and other immune diseases. You can subscribe by simply entering your name and email address in the section under ASCIA Update on the right hand side of the ASCIA website homepage www.allergy.org.au 

Subscriber details remain confidential. To review our privacy information go to www.allergy.org.au/about-ascia/disclaimer-and-privacy#privacy  

If you no longer wish to receive the ASCIA Update e-newsletter you can unsubscribe at any time. 

Previous issues are available open access at www.allergy.org.au/about-ascia/updates 

A brief history of ASCIA

There have been considerable advances in our knowledge of immune system disorders over the last 50 years through research and clinical practice. This has resulted in:

  • Improved diagnosis and management of allergy and other immune diseases
  • Collaborative world class allergy and immunology research in Australasia
  • Development of ASCIA as the peak body for allergy and clinical immunology in Australasia

In 1953 the Australian Society of Allergists (ASA) was registered under the auspice of the British Medical Association (Australia) and in 1962 the ASA was incorporated. 

In 1970 the Australasian Society for Immunology (ASI) was established and ASA became the Australian College of Allergists, which later changed its name and constitution to become the Australian College of Allergy (ACA).

In 1990 the Australasian Society of Clinical Immunology and Allergy (ASCIA) was established, by amalgamating the ACA with the ASI Clinical Immunology Group (CIG). (Reference: Donald, Gwen. ACA Newsletter 9; 1990).

Since 1990 ASCIA has grown into a world leading, innovative and active professional society with strong and progressive leadership.  For a listing of past ASCIA Presidents go to www.allergy.org.au/members/ascia-past-presidents 

From 1990 to 2000, ASCIA built a strong foundation for the future, including:

  • Hosting of ASCIA Annual Scientific Meetings.
  • Successful bidding and hosting of the World Allergy Congress in 2000.
  • Development of a new Strategic Plan in 1999-2000, with a focus on web based education.

From 2000 to 2010 ASCIA established an education focus, including:

  • Implementation of a new Strategic Plan with an emphasis on open access web based educational resources for patients and health professionals.
  • Development of the first versions of ASCIA Action Plans for Anaphylaxis in 2003, that are now recognised as world leading resources.
  • Development of the first version of ASCIA infant feeding advice in 2008. 
  • Management of its own Annual Scientific Meetings since 2006.
  • Development of the first free of charge ASCIA anaphylaxis e-training courses (for schools and childcare services) in 2010.

From 2010 to 2018 ASCIA has significantly expanded its education, training, advocacy and strategic planning, including:

  • Development of a wide range of free of charge ASCIA e-training courses for health professionals, schools, childcare and the public.
  • New and updated ASCIA action plans, guidelines and other resources that promote high standards, available open access from ASCIA website.
  • Collaborations to improve patient care, including TAPID (transplantation and PID) and AusPollen projects.
  • Establishment of AIFA (Allergy and Immunology Foundation of Australasia) in 2013, to fund research and raise awareness.
  • Management of ASCIA Annual Conferences since 2014 (replacing the ASCIA Annual Scientific Meetings).
  • Development of new ASCIA guidelines for infant feeding and allergy prevention in 2016.
  • Comprehensive review and updating of ASCIA website information in 2017.
  • Development and implementation of the first National Allergy Strategy for Australia, in partnership with Allergy & Anaphylaxis Australia and key stakeholders. 
  • 250K for young people will severe allergies was the 1st NAS project launched in 2017 www.250K.org.au 
  • All About Allergens training for food service was the 2nd NAS project launched in 2017 www.foodallergytraining.org.au 

For more information go to www.allergy.org.au/about-ascia/ascia-initiatives

Content updated September 2019

Mod ASCIA Member
Donate to AIFA
go to NAS website

ASCIA is the peak professional body of clinical immunology and allergy in Australia and New Zealand
ASCIA promotes and advances the study and knowledge of allergy and other immune diseases

Quick Links


ASCIA is a registered trademark of the Australasian Society of Clinical Immunology and Allergy. All content is subject to copyright for the Australasian Society of Clinical Immunology and Allergy. Read more...

The content for the website is developed and approved by ASCIA Committee and ASCIA Working Party Members. Read more...

Disclaimer I Privacy

The ASCIA website is intended for use by ASCIA members, health professionals and the general public. The content provided is for education, communication and information purposes only and is not intended to replace or constitute medical advice or treatments. Read more...

ASCIA respects your privacy. Read our privacy policy here...

Sponsors | Advertising

ASCIA does not endorse products from sponsoring organisations, nor is it influenced by sponsoring organisations with regard to the content of education programs and websites. 

The ASCIA website does not accept advertising. Any link to a third-party website does not imply any endorsement by ASCIA.


This website is certified by Health On the Net Foundation. Click to verify.This site complies with the HONcode standard for trustworthy health information.Verify here.